Haemonetics Corporation logo

Haemonetics Corporation (HAE)

Market Closed
4 Jun, 20:00
NYSE NYSE
$
69. 85
+3.97
+6.0261%
$
3.05B Market Cap
34.22 P/E Ratio
- Div Yield
1.08M Volume
3.96 Eps
$ 65.88
Previous Close
Add Transaction
Day Range
66.44 69.95
Year Range
47.32 87.32
Want to track HAE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy?

Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Haemonetics (HAE) Banks on Growing Plasma Arm, Innovation

Haemonetics (HAE) Banks on Growing Plasma Arm, Innovation

Haemonetics (HAE) is gaining from the newly completed limited market release of the new Express Plus technology with more than 60,000 real-world collections.

Zacks | 1 year ago
Don't Overlook These Highly Ranked Medical Stocks as Markets Rise

Don't Overlook These Highly Ranked Medical Stocks as Markets Rise

With earnings estimate revisions on the rise for these top medical stocks, they certainly shouldn't be overlooked given their blazing historical performances.

Zacks | 1 year ago
Best Momentum Stocks to Buy for June 6th

Best Momentum Stocks to Buy for June 6th

HAE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 6, 2024.

Zacks | 1 year ago
New Strong Buy Stocks for June 6th

New Strong Buy Stocks for June 6th

HWM, LGND, MATX, SMFKY and HAE have been added to the Zacks Rank #1 (Strong Buy) List on June 6, 2024.

Zacks | 1 year ago
These 3 Companies Boast Bright Outlooks

These 3 Companies Boast Bright Outlooks

Listening to the Zacks Rank can consistently result in market-beating gains, as positive earnings estimate revisions provide the fuel needed for shares to move higher.

Zacks | 2 years ago
Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term

Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 years ago
Here's Why Haemonetics (HAE) is a Strong Value Stock

Here's Why Haemonetics (HAE) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 years ago
3 Highly Ranked Medical Stocks Added to the Zacks Strong Buy List

3 Highly Ranked Medical Stocks Added to the Zacks Strong Buy List

Considering the stretched premiums many groundbreaking healthcare companies can command, these medical stocks are worthy of investors' interest given their attractive P/E valuations and the positive trend of earnings estimate revisions.

Zacks | 2 years ago
Best Momentum Stocks to Buy for May 28th

Best Momentum Stocks to Buy for May 28th

MNSO, LSPD and HAE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 28, 2023.

Zacks | 2 years ago
3 Reasons Why Growth Investors Shouldn't Overlook Haemonetics (HAE)

3 Reasons Why Growth Investors Shouldn't Overlook Haemonetics (HAE)

Haemonetics (HAE) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 2 years ago
HAE or BSX: Which Is the Better Value Stock Right Now?

HAE or BSX: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with Haemonetics (HAE) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 2 years ago
Loading...
Load More